Unique ID issued by UMIN | UMIN000011587 |
---|---|
Receipt number | R000013417 |
Scientific Title | A pilot evaluation of safety and efficacy of usutekinumab in Takayasu arteritis |
Date of disclosure of the study information | 2013/10/01 |
Last modified on | 2015/08/28 20:54:27 |
A pilot evaluation of safety and efficacy of usutekinumab in Takayasu arteritis
TAKUS-Free Pilot Study
A pilot evaluation of safety and efficacy of usutekinumab in Takayasu arteritis
TAKUS-Free Pilot Study
Japan |
Takayasu arteritis
Clinical immunology |
Others
NO
To evaluate whether usutekinumab, monoclonal antibodies against IL-12/23 p40 that are practically used to treat psoriasis vulgaris, are safe and effective in Takayasu arteritis cases
Safety,Efficacy
Exploratory
Pragmatic
Phase II
1. Safety
a) Serious adverse events (anaphylaxis, hypotension, angioedema and serious viral/bacterial/fungal infections such as tuberculosis, cellulitis, diverticulitis, osteomyelitis, gastroenteritis, pneumonia and urinary tract infection)
b) Symptoms related with adverse events (skin rash, sore throat, cough, sputum, dyspnea on efforts, chest pain, chest tightness, nausea, abdominal pain, diarrhea and frequent urination)
c) Abnormal data in general laboratory tests (Complete blood count, biochemical examination)
2. Efficacy
a) Improved visual analogue scales (headache, neck pain, easy fatigability of arms, easy fatigability of body, muscle pain)
b) Improved biomarkers (CRP, ESR, matrix metalloproteinase-9)
c) Improved findings in images (MR angiography, carotid artery US)
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Medicine |
Subcutaneous injection of usutekinumab (45 mg/body, 0 and 4th week)
Not applicable |
Not applicable |
Male and Female
1) A case who was diagnosed as having Takayasu arteritis using the classification criteria (2006-2007) of Ministry of Health, Labour and Welfare, Japan and who is attending to Department of Rheumatology and Clinical Immunology, Kyoto University Hospital
2) A case who has either an HLA-B*52:01 allele or a risk allele of IL-12B SNPs
3) A case with uncontrolled or recurrent symptoms such as fever, neck pain, headache and easy fatigability even after use of glucocorticoids and immunosuppressive agents
1) A case who is suspected of having active or latent tuberculosis or of type B hepatitis by the results of a tuberculin test, chest X-ray or laboratory tests
3
1st name | |
Middle name | |
Last name | Hajime Yoshifuji |
Graduate School of Medicine, Kyoto University
Department of Rheumatology and Clinical Immunology
54 Shogoin-Kawahara-cho, Sakyo-ku, Kyoto, 606-8507 JAPAN
075-751-3793
yossii@kuhp.kyoto-u.ac.jp
1st name | |
Middle name | |
Last name | Hajime Yoshifuji |
Graduate School of Medicine, Kyoto University
Department of Rheumatology and Clinical Immunology
54 Shogoin-Kawahara-cho, Sakyo-ku, Kyoto, 606-8507 JAPAN
075-751-3793
yossii@kuhp.kyoto-u.ac.jp
Department of Rheumatology and Clinical Immunology
Graduate School of Medicine, Kyoto University
Japan Rheumatism Foundation
Non profit foundation
NO
京都大学大学院医学部附属病院
2013 | Year | 10 | Month | 01 | Day |
Published
Main results already published
2013 | Year | 09 | Month | 30 | Day |
2013 | Year | 10 | Month | 01 | Day |
2014 | Year | 06 | Month | 20 | Day |
2014 | Year | 12 | Month | 26 | Day |
2015 | Year | 01 | Month | 01 | Day |
2015 | Year | 02 | Month | 05 | Day |
2013 | Year | 08 | Month | 27 | Day |
2015 | Year | 08 | Month | 28 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000013417
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |